<DOC>
	<DOC>NCT00282568</DOC>
	<brief_summary>A study to assess the pharmacokinetics, safety and effectiveness of tacrolimus in stable kidney transplant patients converted from a Prograf速 based immunosuppression regimen to a modified release tacrolimus based immunosuppression regimen.</brief_summary>
	<brief_title>A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients</brief_title>
	<detailed_description>This is a Phase II open-label, multi-center conversion study in stable, adult kidney transplant recipients to assess the pharmacokinetics, safety and effectiveness of tacrolimus in stable kidney transplant patients converted from a Prograf速 based immunosuppression regimen to a modified release tacrolimus based immunosuppression regimen.</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patient is currently receiving Prograf 速 based immunosuppressive therapy for kidney transplantation. Patient has stable whole blood trough level concentrations of Prograf速 and is clinically stable Patient has previously received an organ transplant other than a kidney Patient is currently receiving sirolimus immunosuppression therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Therapy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Drugs, Investigational</keyword>
	<keyword>Adult</keyword>
</DOC>